V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260018700 | 260009410 | null | 85.1 | Neo-adjuvant (N) | 2018-05-09 | 2018-06-29 | ABVD | N | N | 260028377 | ESHAP R |
| 260018701 | 260009418 | 1.54 | 90.6 | Palliative (P) | 2017-11-01 | 2017-11-04 | METHOTREXATE | 2 | N | 260028398 | DHAP - R |
| 260018702 | 260009420 | 1.81 | 98 | Curative (C) | null | 2018-06-17 | IBRUTINIB | N | N | 260028402 | BEACOPP |
| 260018703 | 260009424 | 1.7 | 55.3 | Curative (C) | 2015-12-16 | 2016-04-01 | ACE (germ cell) | N | null | 260028405 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018704 | 260009433 | 1.56 | 74 | Disease modification (D) | 2017-04-23 | 2017-05-05 | Cyclophosphamide High Dose | 2 | N | 260028436 | PIXANTRONE |
| 260018705 | 260009442 | 1.68 | 83.4 | Curative (C) | 2016-06-05 | 2016-10-01 | R CODOX-M/ R IVAC | 02 | N | 260028451 | CISPLATIN + GEMCITABINE |
| 260018706 | 260009450 | 1.61 | 75.4 | Curative (C) | 2016-07-23 | 2016-07-25 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260028467 | BLEOMYCIN |
| 260018707 | 260009453 | null | 77.7 | null | 2016-08-01 | 2017-03-31 | CVP | N | null | 260028487 | CVP |
| 260018708 | 260009457 | null | 74.8 | Adjuvant (A) | 2016-01-15 | 2016-02-12 | CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260028489 | CYCLOPHOSPHAMIDE |
| 260018709 | 260009464 | 1.81 | 77.6 | Adjuvant (A) | 2017-08-18 | 2017-08-31 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 260028515 | CARBOPLATIN + ETOPOSIDE |
| 260018710 | 260009472 | null | 94.3 | Curative (C) | 2018-12-02 | 2018-12-03 | Carboplatin + Etoposide IV 3 day | N | N | 260028530 | GEMCITABINE + OXALIPLATIN |
| 260018711 | 260014515 | 1.69 | 93 | Palliative (P) | 2013-07-29 | 2013-09-24 | TRASTUZUMAB | 2 | N | 260028569 | NIVOLUMAB |
| 260018712 | 260009495 | null | 67.4 | Palliative (P) | 2015-03-29 | 2015-04-20 | VIP | 2 | N | 260028610 | EP |
| 260018713 | 260009497 | 1.64 | 51.4 | Palliative (P) | 2016-08-28 | 2017-05-12 | Carboplatin 21day + Paclitaxel 7day | null | null | 260028618 | CHOP |
| 260018714 | 260009500 | 1.86 | 86.8 | Curative (C) | 2018-06-09 | 2018-06-15 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260028633 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260018715 | 260009502 | 0 | 90 | Curative (C) | 2017-09-30 | 2017-12-02 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260028634 | GEMCITABINE + OXALIPLATIN + PACLITAXEL |
| 260018716 | 260014521 | 1.63 | 77 | Not known (9) | 2016-11-22 | 2016-12-01 | CARBO + THIOTEPA + TOPOTECAN | 02 | N | 260028637 | PANITUMUMAB |
| 260018717 | 260009507 | 1.78 | 85.7 | null | null | 2015-09-02 | ICE + GCSF | N | null | 260028641 | IFOSFAMIDE + PACLITAXEL |
| 260018718 | 260014529 | null | 129.6 | Curative (C) | 2018-04-28 | 2018-04-28 | CYTARABINE + METHOTREXATE HD | N | N | 260028717 | OSIMERTINIB |
| 260018719 | 260014532 | null | 96.1 | Adjuvant (A) | 2015-10-13 | 2015-10-16 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | null | null | 260028731 | BOP |
| 260018720 | 260009528 | 1.7 | 96.2 | Curative (C) | 2018-11-11 | 2018-11-11 | TRASTUZUMAB | 02 | N | 260028757 | CARBOPLATIN + PACLITAXEL |
| 260018721 | 260009538 | 1.71 | 67.5 | Curative (C) | 2014-06-03 | 2014-06-03 | Cetuximab 7 day (>Cycle 2) | 02 | N | 260028790 | PEMETREXED |
| 260018722 | 260014546 | 1.83 | null | Adjuvant (A) | 2015-08-02 | 2015-08-09 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 2 | N | 260028814 | PEMBROLIZUMAB |
| 260018723 | 260009551 | 1.8 | 101.4 | Disease modification (D) | 2014-03-15 | 2014-10-22 | ACE (germ cell) | 02 | N | 260028818 | CAPECITABINE + RT |
| 260018724 | 260009556 | 0 | 88 | Palliative (P) | 2015-09-02 | 2015-09-06 | BLEOMYCIN + CISPLATIN + VINCRISTINE | null | null | 260028854 | GEMCITABINE + OXALIPLATIN |
| 260018725 | 260016969 | 1.77 | 71.9 | Curative (C) | 2018-03-28 | 2018-03-28 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 2 | N | 260028878 | IFOSFAMIDE + PACLITAXEL |
| 260018726 | 260009576 | 1.63 | 56.45 | null | 2017-12-05 | 2018-01-03 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260028923 | VIP |
| 260018727 | 260009581 | 1.82 | 72.8 | Curative (C) | 2019-01-10 | 2019-01-10 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | null | 260028943 | ESHAP |
| 260018728 | 260014567 | 1.71 | 87 | Curative (C) | 2017-05-23 | 2017-05-29 | GEMCITABINE + TIP | N | N | 260028978 | BLEOMYCIN |
| 260018729 | 260009595 | 1.82 | 94.5 | Disease modification (D) | 2019-03-20 | 2019-03-28 | BLEOMYCIN + VINCRISTINE | N | N | 260028993 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL |
| 260018730 | 260009605 | 1.75 | 79.75 | Curative (C) | 2018-09-30 | 2019-02-27 | Carboplatin + Etoposide IV 3 day | N | N | 260029017 | ACE (GERM CELL) |
| 260018731 | 260018185 | 1.7 | 56 | Disease modification (D) | 2018-06-24 | 2018-09-26 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 260029021 | PEMBROLIZUMAB |
| 260018733 | 260009623 | 1.76 | 88.8 | Palliative (P) | 2018-09-16 | 2018-09-19 | ACE (germ cell) | 02 | N | 260029065 | IPO |
| 260018734 | 260009624 | null | null | Curative (C) | 2018-04-16 | 2018-05-17 | CISPLATIN + ETOPOSIDE + PACLITAXEL | N | null | 260029067 | IVA |
| 260018735 | 260009647 | 1.63 | 77 | Palliative (P) | 2018-02-18 | 2018-03-18 | PEMBROLIZUMAB | N | N | 260029135 | PEMBROLIZUMAB |
| 260018736 | 260009650 | 1.78 | 49 | Palliative (P) | 2018-09-13 | 2018-12-07 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260029137 | IPO |
| 260018737 | 260009661 | 1.69 | 71.1 | Curative (C) | 2018-10-17 | 2018-10-17 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 2 | N | 260029169 | CARBO + THIOTEPA + TOPOTECAN |
| 260018738 | 260009664 | 1.65 | 74.8 | Palliative (P) | 2015-10-20 | 2015-10-20 | IFOSFAMIDE + PACLITAXEL | N | N | 260029198 | IPO |
| 260018739 | 260014595 | 1.7 | 78.9 | Curative (C) | 2015-10-29 | 2015-11-14 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260029201 | POMB |
| 260018740 | 260009666 | null | 95.9 | Curative (C) | 2018-03-02 | 2018-09-09 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | N | 260029207 | IVADO |
| 260018741 | 260009677 | 1.63 | 62.6 | null | 2018-09-22 | 2018-09-23 | CYCLOPHOSPHAMIDE | 02 | N | 260029236 | CISPLATIN + RT |
| 260018742 | 260009680 | 1.69 | 67.4 | Neo-adjuvant (N) | null | 2017-02-20 | DOXORUBICIN | 2 | N | 260029241 | IVA |
| 260018743 | 260009693 | 1.8 | 76.4 | Disease modification (D) | 2018-10-20 | 2018-10-23 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | N | 260029288 | CARBO + THIOTEPA + TOPOTECAN |
| 260018744 | 260009695 | null | 52 | Curative (C) | null | 2017-12-15 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL | N | N | 260029313 | BLEOMYCIN + VINCRISTINE |
| 260018745 | 260019105 | 1.82 | 83.9 | Palliative (P) | null | 2014-05-26 | PEMBROLIZUMAB | N | N | 260029346 | EP |
| 260018746 | 260009705 | 1.79 | 74.5 | null | 2015-10-03 | 2015-10-04 | CARBO + THIOTEPA + TOPOTECAN | null | null | 260029348 | CYCLOPHOSPHAMIDE |
| 260018747 | 260009708 | 1.61 | 82.9 | Disease modification (D) | 2016-08-29 | 2017-04-02 | GEMCITABINE + TIP | 02 | Y | 260029356 | IFOSFAMIDE + PACLITAXEL |
| 260018748 | 260009725 | 1.68 | 84.6 | Palliative (P) | 2015-09-10 | 2015-09-17 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 260029421 | VIP |
| 260018749 | 260009729 | null | 103 | Palliative (P) | 2018-04-20 | 2018-05-17 | BLEOMYCIN | N | N | 260029426 | CARBOPLATIN + ETOPOSIDE |
| 260018750 | 260009731 | 1.59 | 66 | Palliative (P) | 2015-03-07 | 2015-03-27 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 260029427 | CETUXIMAB |